Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure-activity relationships

被引:79
作者
Altomare, C
Cellamare, S
Summo, L
Catto, M
Carotti, A
Thull, U
Carrupt, PA
Testa, B
Stoeckli-Evans, H
机构
[1] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
[2] Univ Lausanne, Inst Chim Therapeut, Pharm Sect, CH-1015 Lausanne, Switzerland
[3] Univ Neuchatel, Inst Chim, Fac Sci, CH-2000 Neuchatel, Switzerland
关键词
D O I
10.1021/jm981005y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of condensed pyridazines and pyrimidines were synthesized and tested for their monoamine oxidase-A (MAO-A) and MAO-B inhibitory activity. Their lipophilicity was examined by measuring partition coefficients and RP-HPLC capacity factors, revealing some peculiar electronic and conformational effects. Further insights were obtained by X-ray crystallography and a thermodynamic study of RP-HPLC retention. Structure-activity relations highlighted the main factors determining both selectivity and inhibitory potency. Thus, while most of the condensed pyridazines were reversible inhibitors of MAO-B with little or no MAO-A effects, the pyrimidine derivatives proved to be reversible and selective MAO-A inhibitors. Substituents on the diazine nucleus modulated enzyme inhibition. A QSAR analysis of X-substituted 3-X-phenyl-5H-indeno[1,2-c]pyridazin-5-ones showed lipophilicity to increase MAO-B and not MAO-A inhibitory activity.
引用
收藏
页码:3812 / 3820
页数:9
相关论文
共 57 条
  • [1] ALLAIN, 1997, PROGR MED CHEM, V34, P1
  • [2] QUANTITATIVE STRUCTURE METABOLISM RELATIONSHIP ANALYSES OF MAO-MEDIATED TOXICATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ANALOGS
    ALTOMARE, C
    CARRUPT, PA
    GAILLARD, P
    ELTAYAR, N
    TESTA, B
    CAROTTI, A
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (03) : 366 - 375
  • [3] ALTOMARE C, 1994, FARMACO, V49, P313
  • [4] CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES
    BACH, AWJ
    LAN, NC
    JOHNSON, DL
    ABELL, CW
    BEMBENEK, ME
    KWAN, SW
    SEEBURG, PH
    SHIH, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4934 - 4938
  • [5] *BIOB CORP, MACL P 2 0 PROGR
  • [6] Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients
    Bongioanni, P
    Mondino, C
    Boccardi, B
    Borgna, M
    Castagna, M
    [J]. NEURODEGENERATION, 1996, 5 (04): : 351 - 357
  • [7] CAROTTI A, 1993, FARMACO, V48, P137
  • [8] CORRELATION BETWEEN MONOAMINO OXIDASE INHIBITOR ACTIVITY OF SOME THIAZOL-2-YLHYDRAZINES AND THEIR INTERACTION WITH DIPALMITOYLPHOSPHATIDYLCHOLINE LIPOSOMES
    CASTELLI, F
    PIGNATELLO, R
    SARPIETRO, MG
    MAZZONE, P
    RACITI, G
    MAZZONE, G
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (03) : 362 - 366
  • [9] Cesura A M, 1992, Prog Drug Res, V38, P171
  • [10] CLARK JB, 1970, J BIOL CHEM, V245, P4724